Skip to Content

Zamansky LLC Investigates Affymax Inc. Over Its Recall of Omontys Due to Fatal Reactions

May 7, 2013 In The News

Zamansky LLC notifies all investors in Affymax Inc. (“Affymax”) that it is investigating the recall of Omontys, its anemia treatment for kidney dialysis patients due to reports of fatal reactions, for possible securities fraud or disclosure law violations.
Read the full Press Release